Compare HAS & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAS | TECH |
|---|---|---|
| Founded | 1923 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 9.2B |
| IPO Year | N/A | 1989 |
| Metric | HAS | TECH |
|---|---|---|
| Price | $86.17 | $68.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $90.70 | $70.46 |
| AVG Volume (30 Days) | 1.5M | ★ 1.9M |
| Earning Date | 02-19-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.25% | 0.47% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $4,357,000,000.00 | $1,216,732,000.00 |
| Revenue This Year | $10.19 | $2.33 |
| Revenue Next Year | $5.40 | $6.89 |
| P/E Ratio | ★ N/A | $141.08 |
| Revenue Growth | 0.79 | ★ 3.85 |
| 52 Week Low | $49.00 | $46.01 |
| 52 Week High | $89.20 | $79.28 |
| Indicator | HAS | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 71.79 |
| Support Level | $84.38 | $63.91 |
| Resistance Level | $87.38 | $70.66 |
| Average True Range (ATR) | 1.96 | 2.25 |
| MACD | 0.01 | 0.88 |
| Stochastic Oscillator | 60.13 | 86.46 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.